Immunotherapy for All Cancers

Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link
The Answer to Cancer

Immunotherapy is the answer to cancer for many patients around the world. Below is a growing list of specific cancer types for which immunotherapy has shown promising results. If you don't see your cancer type listed here, check back regularly as we continue to add new cancer types—or better yet, sign up for our newsletter to stay informed on the development of new immunotherapy treatments.

Bladder Cancer
Bladder cancer, the 6th most common cancer in the US, was the first cancer type for which an immunotherapy was granted approval by the FDA in 1990.
Brain Cancer
Malignant brain tumors are relatively rare but very serious form of cancer. Immunotherapy is showing significant promise where other approaches have failed.
Breast Cancer
New immunotherapies are currently being tested in breast cancer clinical trials and several have shown impressive results.
Cervical Cancer
Infection with human papillomavirus (HPV) is thought to cause nearly all cases of cervical cancer, and almost all anal, vaginal, vulvar, and penile cancers.
Childhood Cancer
Cancer affects an estimated 300,000 young people every year. Immunotherapy has the potential to improve both their survival and quality of life.
Colorectal Cancer
Immunotherapy is a new treatment approach for patients with colorectal cancer, cancer that starts in the colon or the rectum—parts of the digestive system.
Esophageal Cancer
There are two main types of esophageal cancer: squamous cell carcinoma, beginning in the esophagus lining, and adenocarcinoma, starting in cells that make and release mucus.
Head and Neck Cancer
“Head and neck cancer” is a collective term that includes several different types of cancers, including the mouth, throat, voice box, sinuses and nose cavity, and salivary glands.
Kidney Cancer
Treatment for kidney cancer depends on individual factors, including exact location of the tumor, stage of the tumor, and the person’s general health.
Leukemia is cancer of the bone marrow and lymphatic system. In leukemia, abnormal cells, produced by bone marrow, begin to overtake and replace normal blood and marrow cells.
Liver Cancer
Primary liver cancer is one of the major cancer types for which new immune-based cancer treatments are currently in development.
Lung Cancer
Lung cancer is one of the most common types of cancer worldwide. Immunotherapy is greatly improving treatment and prognosis for patients with lung cancer.
Lymphoma is a relatively uncommon but very serious cancer. Immunotherapies are showing significant promise where other approaches have failed.
Melanoma has traditionally been treated surgically. However, it is also one of the cancers most responsive to immunotherapy.
Multiple Myeloma
The Cancer Research Institute supports scientists currently working to bring effective immune-based cancer treatments to people with multiple myeloma.
Ovarian Cancer
Ovarian cancer may respond to chemotherapy, however, up to 80% of women relapse. Immunotherapy represents one new avenue for these women.
Pancreatic Cancer
Pancreatic cancer is a relatively uncommon but very serious cancer. Immunotherapies are showing significant promise where other approaches have failed.
Prostate Cancer
Prostate cancer is the one of the most commonly occurring cancers in American men. Immunotherapy is an exciting area of treatment for prostate cancer.
Sarcoma is a rare cancer in adults (1% of all adult cancers), but rather prevalent in children (about 15% of all childhood cancers). Most bone sarcomas are more common in children.
Stomach Cancer
Treatment of stomach cancer depends on where the cancer started and how far it has spread. Immunotherapy for stomach cancer has shown promise in early clinical trials.

*Immunotherapy results may vary from patient to patient.

Patient education information supported by a charitable donation from Bristol-Myers Squibb Company.